Spinal muscular atrophy type III: Trying to understand subtle functional change over time-a case report

Journal of Child Neurology

Volumn 27, Issue 6, 2012, Pages 779-785

  Dunaway, Sally ^a   Montes, Jacqueline ^a   Ryan, Patricia A ^b   Montgomery, Megan ^a   Sproule, Douglas M ^a   Vivo, Darryl C De ^a  

^a Department of Medicine   (United States)

^b NEW YORK PRESBYTERIAN HOSPITAL   (United States)

Author keywords

functional changes; natural history; outcome measures; spinal muscular atrophy

Indexed keywords

VALPROIC ACID;

ARTICLE; CASE REPORT; CHILD; CHRONIC DISEASE; FEMALE; FOLLOW UP; FUNCTIONAL ASSESSMENT; GROSS MOTOR FUNCTION MEASURE; HUMAN; LUNG FUNCTION; MOTOR PERFORMANCE; MUSCLE STRENGTH; OUTCOME ASSESSMENT; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; SPINAL MUSCULAR ATROPHY; SPINAL MUSCULAR ATROPHY TYPE III;

ANTICONVULSANTS; CHILD; EARLY INTERVENTION (EDUCATION); EXHALATION; FEMALE; HUMANS; LONGITUDINAL STUDIES; MOTOR ACTIVITY; MUSCLE STRENGTH; OUTCOME ASSESSMENT (HEALTH CARE); RECOVERY OF FUNCTION; SPINAL MUSCULAR ATROPHIES OF CHILDHOOD; VALPROIC ACID; WALKING;

EID: 84861325635     PISSN: 08830738     EISSN: 17088283     Source Type: Journal    
DOI: 10.1177/0883073811425423     Document Type: Article

References (46)

1. Crawford TO Neuromuscular Disorders of Infancy, Childhood, and Adolescence: A Clinician's Approach. Jones RH De Vivo DC Darras BT, ed. Philadelphia, PA: Butterworth Heinemann ; 2003: 145-166.
2. Dubowitz V. Chaos in the classification of SMA: a possible resolution. Neuromuscul Disord. 1995 ; 5 (1). 3-5
3. Kaufmann P, McDermott MP, Darras BT, et al. Muscle Study Group; Pediatric Neuromuscular Clinical Research Network for Spinal Muscular Atrophy. Observational study of spinal muscular atrophy type 2 and 3: functional outcomes over 1 year. Arch Neurol. 2011 ; 68 (6). 779-786
4. Zerres K, Rudnik-Schoneborn S.. Natural history in proximal spinal muscular atrophy: clinical analysis of 445 patients and suggestions for a modification of existing classifications. Arch Neurol. 1995 ; 52 (5). 518-523
5. Zerres K, Rudnik-Schoneborn S, Forrest E, Lusakowska A, Borkowska J, Hausmanowa-Petrusewicz I. A collaborative study on the natural history of childhood and juvenile onset proximal spinal muscular atrophy (type II and III SMA): 569 patients. J Neurol Sci. 1997 ; 146 (1). 67-72
6. Deymeer F, Serdaroglu P, Parman Y, Poda M. Natural history of SMA IIIB. Neurology. 2008 ; 71: 664-649
7. Kroksmark AK, Beckung E, Tulinius M. Muscle strength and motor function in children and adolescents with spinal muscular atrophy II and III. Eur J Paediatr Neurol. 2001 ; 5 (5). 191-198
8. Russman BS, Buncher CR, White M, Samaha FJ, Iannaccone ST. Function changes in spinal muscular atrophy II and III. The DCN/SMA Group. Neurology. 1996 ; 47 (4). 973-976
9. Escolar DM, Henricson EK, Mayhew J, et al. Clinical evaluator reliability for quantitative and manual muscle testing measures of strength in children. Muscle Nerve. 2001 ; 24 (6). 787-793
10. Swoboda KJ, Prior TW, Scott CB, et al. Natural history of denervation in SMA: relation to age, SMN2 copy number, and function. Ann Neurol. 2005 ; 57 (5). 704-712
11. Nelson L, Owens H, Hynan LS, Iannaccone ST. The gross motor function measure is a valid and sensitive outcome measure for spinal muscular atrophy. Neuromuscul Disord. 2006 ; 16 (6). 374-380
12. Main M, Kairon H, Mercuri E, Muntoni F. The Hammersmith functional motor scale for children with spinal muscular atrophy: a scale to test ability and monitor progress in children with limited ambulation. Eur J Paediatr Neurol. 2003 ; 7 (4). 155-159
13. O'Hagen J M, Glanzman AM, McDermott MP, et al. An expanded version of the Hammersmith Functional Motor Scale for SMA II and III patients. Neuromuscul Disord. 2007 ; 17 (9-10). 693-697
14. Florence JM, Pandya S, King WM, et al. Intrarater reliability of manual muscle test (Medical Research Council scale) grades in Duchenne's muscular dystrophy. Phys Ther. 1992 ; 72 (2). 115-122
15. Scott OM, Hyde SA, Goddard C, Dubowitz V. Quantitation of muscle function in children: a prospective study in Duchenne muscular dystrophy. Muscle Nerve. 1982 ; 5 (4). 291-301
16. Werlauff U, Steffensen BF, Bertelsen S, Floytrup I, Kristensen B, Werge B. Physical characteristics and applicability of standard assessment methods in a total population of spinal muscular atrophy type II patients. Neuromuscul Disord. 2010 ; 20: 34-43
17. Deymeer F, Serdaroglu P, Poda M, Gulsen-Parman Y, Ozcelik T, Ozdemir C. Segmental distribution of muscle weakness in SMA III: implications for deterioration in muscle strength with time. Neuromuscul Disord. 1997 ; 7: 521-528
18. Merlini L, Bertini E, Minetti C, et al. Motor function-muscle strength relationship in spinal muscular atrophy. Muscle Nerve. 2004 ; 29: 548-552
19. Carter GT, Abresch RT, Fowler WM, Johnson ER, Kilmer DD, McDonald CM. Profiles of neuromuscular diseases. Spinal muscular atrophy. Am J Phys Med Rehabil. 1995 ; 74 (5 suppl). S150 - S159
20. Wang HY, Yang YH, Jong YJ. Evaluation of muscle strength in patients with spinal muscular atrophy. Kaohsiung J Med Sci. 2002 ; 18 (5). 241-247
21. Koch BM, Simenson RL. Upper extremity strength and function in children with spinal muscular atrophy type II. Arch Phys Med Rehabil. 1992 ; 73 (3). 241-245
22. Merlini L, Mazzone ES, Solari A, Morandi L. Reliability of hand-held dynamometry in spinal muscular atrophy. Muscle Nerve. 2002 ; 26 (1). 64-70
23. Wang X, Dockery DW, Wypij D, Fay ME, Ferris BG. Pulmonary function between 6 and 18 years of age. Pediatr Pulmonol. 1993 ; 15 (2). 75-88
24. Iannaccone ST. Outcome measures for pediatric spinal muscular atrophy. Arch Neurol. 2002 ; 59 (9). 1445-1450
25. Armon C, Brandstater ME. Motor unit number estimate-based rates of progression of ALS predict patient survival. Muscle Nerve. 1999 ; 22 (11). 1571-1575
26. Galea V, Fehlings D, Kirsch S, McComas A. Depletion and sizes of motor units in spinal muscular atrophy. Muscle Nerve. 2001 ; 24 (9). 1168-1172
27. Haley SM, Ludlow LH. Applicability of the hierarchical scales of the Tufts Assessment of Motor Performance for school-aged children and adults with disabilities. Phys Ther. 1992 ; 72 (3)). 191-202
28. Feldman AB, Haley SM, Coryell J. Concurrent and construct validity of the Pediatric Evaluation of Disability Inventory. Phys Ther. 1990 ; 70 (10). 602-610
29. Berg M, Jahnsen R, Froslie KF, Hussain A. Reliability of the Pediatric Evaluation of Disability Inventory (PEDI). Phys Occup Ther Pediatr. 2004 ; 24 (3). 61-77
30. Parano E, Fiumara A, Falsaperla R, Pavone L. A clinical study of childhood spinal muscular atrophy in Sicily: a review of 75 cases. Brain Dev. 1994 ; 16 (2). 104-107
31. Steffensen BF, Lyager S, Werge B, Rahbek J, Mattsson E. Physical capacity in non-ambulatory people with Duchenne muscular dystrophy or spinal muscular atrophy: a longitudinal study. Dev Med Child Neurol. 2002 ; 44 (9). 623-632
32. Benady SG. Spinal muscular atrophy in childhood: review of 50 cases. Dev Med Child Neurol. 1978 ; 20 (6). 746-757
33. Munsat TL, Skerry L, Korf B, et al. Phenotypic heterogeneity of spinal muscular atrophy mapping to chromosome 5q11.2-13.3 (SMA 5q). Neurology. 1990 ; 40 (12). 1831-1836
34. Russman BS, Melchreit R, Drennan JC. Spinal muscular atrophy: the natural course of disease. Muscle Nerve. 1983 ; 6 (3). 179-181
35. Barois A, Mayer M, Desguerre I, et al. Spinal muscular atrophy. A 4-year prospective, multicenter, longitudinal study (168 cases) [in French]. Bull Acad Natl Med. 2005 ; 189 (6). 1181-1198
36. Russman BS, Iannacone ST, Buncher CR, et al. Spinal muscular atrophy: new thoughts on the pathogenesis and classification schema. J Child Neurol. 1992 ; 7 (4). 347-353
37. Iannaccone ST, Russman BS, Browne RH, Buncher CR, White M, Samaha FJ. Prospective analysis of strength in spinal muscular atrophy. DCN/Spinal Muscular Atrophy Group. J Child Neurol. 2000 ; 15 (2). 97-101
38. Souchon F, Simard LR, Lebrun S, Rochette C, Lambert J, Vanasse M. Clinical and genetic study of chronic (types II and III) childhood onset spinal muscular atrophy. Neuromuscul Disord. 1996 ; 6 (6). 419-424
39. Schwentker EP, Gibson DA. The orthopaedic aspects of spinal muscular atrophy. J Bone Joint Surg Am. 1976 ; 58 (1). 32-38
40. Mitsumoto H, Ulug AM, Pullman SL, et al. Quantitative objective markers for upper and lower motor neuron dysfunction in ALS. Neurology. 2007 ; 68 (17). 1402-1410
41. Dubowitz V. Muscle disorders in childhood. Major Probl Clin Pediatr. 1978 ; 16 (iii-xiii). 1-282
42. Kanning KC, Kaplan A, Henderson CE. Motor neuron diversity in development and disease. Annu Rev Neurosci. 2010 ; 33: 409-440
43. Bromberg MB, Swoboda KJ. Motor unit number estimation in infants and children with spinal muscular atrophy. Muscle Nerve. 2002 ; 25 (3). 445-447
44. National Institute of Neurological Disorders and Stroke. Spinal Muscular Atrophy (SMA) Biomarker Qualification Workshop. http://www.ninds.nih.gov/news- and-events/proceedings/sma-workshop-summary.htm. Accessed August 4, 2011
45. Barois A, Estournet B, Duval-Beaupere G, Bataille J, Leclair-Richard D. Infantile spinal muscular atrophy [in French]. Rev Neurol (Paris). 1989 ; 145 (4). 299-304
46. Rodillo E, Marini ML, Heckmatt JZ, Dubowitz V. Scoliosis in spinal muscular atrophy: review of 63 cases. J Child Neurol. 1989 ; 4 (2). 118-123